US Broker Ratings

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 74.72% Potential Upside in the Gene Editing Arena

CRISPR Therapeutics AG (NASDAQ: CRSP), a biotechnology powerhouse based in Switzerland, is making waves in the healthcare sector with its innovative approach to gene editing. Leveraging..

LivaNova PLC (LIVN) Stock Analysis: A Compelling 12.31% Upside Potential in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN) stands out in the healthcare sector as a formidable player in the medical devices industry, with a focus on cardiopulmonary and neuromodulation..

HUTCHMED (China) Limited (HCM): Analyst Ratings Signal Potential 44% Upside for Healthcare Innovator

HUTCHMED (China) Limited (NASDAQ: HCM), a Hong Kong-based leader in the healthcare sector, is making waves in the drug manufacturing industry with its expansive portfolio of..

Concentra Group Holdings (CON): Investor Outlook with Strong Buy Ratings and Promising Growth Potential

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a leading player in the healthcare sector, is capturing the attention of investors with its robust growth metrics and..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring the 2,336% Revenue Growth and Its Implications for Investors

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotech firm specializing in groundbreaking therapies for rare endocrine diseases, has recently caught the attention of investors due to..

Oscar Health, Inc. (OSCR) Stock Analysis: A 17.46% Upside Potential Amidst Robust Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) has been carving a niche in the healthcare sector with its innovative technology-driven approach to health insurance. Positioned within the Healthcare..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 93% Potential Upside with Robust CNS Drug Pipeline

For investors with an eye on the biotechnology sector, Axsome Therapeutics, Inc. (NASDAQ: AXSM) presents a compelling opportunity. This biopharmaceutical company, based in New York, specializes..

TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth Potential Amidst Medical Device Innovations

TransMedics Group, Inc. (NASDAQ: TMDX), a formidable player in the healthcare sector, is grabbing investor attention with its cutting-edge contributions to the medical devices industry. Known..

RadNet, Inc. (RDNT) Stock Analysis: Healthcare Diagnostics Leader Offers 34% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare diagnostics sector, is capturing investor attention with a robust market capitalization of $5.54 billion. Known for..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 11.42% Upside in the Booming Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, has been capturing the attention of investors with its innovative solutions..

Halozyme Therapeutics (HALO) Stock Analysis: A Biotech Powerhouse with Rapid Revenue Growth and High ROE

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its robust revenue growth and impressive return on equity..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Exploring a Potential 11% Upside

Bausch + Lomb Corporation (NYSE: BLCO) is an eye health titan with a rich history dating back to 1853. Headquartered in Vaughan, Canada, this company is..

HealthEquity, Inc. (HQY) Stock Analysis: Analyst Consensus and Growth Potential

HealthEquity, Inc. (NASDAQ: HQY), a leading provider in the healthcare information services sector, is gaining traction among investors with its robust growth potential and strong analyst..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Through a Challenging Market with a 9.45% Downside Potential

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specifically in the medical devices industry, has been a pivotal supplier of innovative solutions..

Henry Schein, Inc. (HSIC) Stock Analysis: Potential 14% Upside Amid Robust Revenue Growth

For investors eyeing the healthcare sector, Henry Schein, Inc. (NASDAQ: HSIC) presents an intriguing opportunity. With a market capitalization of $9.68 billion, this medical distribution giant..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Market with a $4.3 Billion Valuation

Integer Holdings Corporation (NYSE: ITGR) stands as a notable player in the medical device industry, commanding a market capitalization of $4.3 billion. Headquartered in Plano, Texas,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 37% Potential Upside Amidst Turbulent Markets

Grifols, S.A. (GRFS), a Spanish healthcare giant specializing in plasma-derived medicines, presents a compelling investment opportunity with a potential upside of 37.10%. With a market capitalization..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Uncovering a 63.64% Upside Potential

BioMarin Pharmaceutical Inc. (BMRN) stands as a prominent player in the biotechnology sector, boasting a market capitalization of $10.83 billion and a portfolio of transformative therapies..

Waystar Holding Corp. (WAY)

⚠️ No article content returned.

..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Potential 22% Upside Amidst Biotech Challenges

Sarepta Therapeutics, Inc. (SRPT) stands at a crucial juncture, balancing its pioneering work in RNA-targeted therapeutics with the financial challenges typical of the biotech sector. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds